Project Grant HT94252510464
Award Date
7/15/25
Completion Date
7/14/28
Dollars Obligated
$4.8M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Tacoma, WA 98402, USA
Similar Awards
The U.S. Defense Health Agency awarded a $909,510 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Geneva Foundation, a non-profit research organization in Tacoma, Washington. The grant supports advanced biomedical research to develop precision therapy for the eradication of brain metastatic breast cancer. The 3-year grant, running from May 2025 to April 2028, will fund innovative research, development, and clinical support services focused on...
The Defense Health Agency awarded a $1,009,750.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation in Tacoma, Washington. The grant, awarded on August 1, 2025, supports the "Genomic and Functional Characterization of Chemoresistance in Small Cell Lung Cancer" research project with a completion date of July 31, 2028. The Geneva Foundation, a non-profit organization focused on medical research and development for the U.S....
The Geneva Foundation received a $4,676,544 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop and validate innate immunome-targeted therapies to create a pro-survival and organ-protective phenotype after hemorrhage at the point of injury. Specifically, the Foundation will investigate immunotherapy approaches for hemorrhage treatments using innate immunome-targeted therapies from July 1, 2023 to...
The U.S. Defense Health Agency awarded a $325,650 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Geneva Foundation, a non-profit research organization based in Tacoma, WA. The grant, awarded on March 1, 2025, will support a 2-year research project to assess changes in the human blood proteome following total sleep deprivation. The Geneva Foundation, which specializes in medical research and development for federal agencies, will likely...
The federal Project Grant award of $6,663,794.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "PRECISIE RTD TRIAL: PRECISION WITH RETURN-TO-DUTY DECISIONS IN THE MILITARY", is focused on delivering incremental funding to advance precision with return-to-duty decisions for military personnel. The primary awardee is The Geneva Foundation, a non-profit organization based in Tacoma, Washington, that...
The Geneva Foundation was awarded a $1,597,740 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 2022 to June 2026 to develop new methods for accessing extracellular vesicle MDM2 DNA cargo as a potential liposarcoma biomarker. Through support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
This Project Grant award for $366,000.00, awarded on Sep 30, 2024 by the Defense Health Agency, supports research conducted by The Geneva Foundation to identify functional structural variants that influence therapy outcomes for human castration-resistant prostate cancer. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which supports a broad range of biomedical research initiatives to improve health outcomes for military service members,...
The U.S. Department of Defense's Defense Health Agency awarded a $488,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation, a non-profit organization. The grant, awarded on July 1, 2024, supports research to investigate novel mechanisms of regulating the PAX3-FOXO1 fusion oncogene in rhabdomyosarcoma, a type of soft tissue cancer. The research aims to advance treatments for this rare and aggressive form of cancer, with a projected...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,065,392.00 to The Geneva Foundation to conduct research on "LOCAL SLEEP IN THE WAKING BRAIN: A NOVEL TARGET FOR COGNITIVE FATIGUE". The project period runs from June 1, 2024 to May 31, 2028. As a non-profit research organization, The Geneva Foundation will perform foundational biomedical research investigating innovative treatments for...
The Defense Health Agency awarded a $410,000 Project Grant titled "Localized and Inflammation-Responsive Immunotherapy of VCA Rejection" to The Geneva Foundation, a 501(c)3 non-profit organization that supports medical research and education for the U.S. military. This grant is part of the "Military Medical Research and Development" program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for Service Members and the public...